Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Kwang Kim

Kwang Sik Kim, M.D.

Director, Pediatric Infectious Diseases
Professor of Pediatrics

Male

Appointment Phone

410-614-0732

Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Director, Pediatric Infectious Diseases
  • Professor of Pediatrics

Centers & Institutes

Departments

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-614-0732

600 N. Wolfe Street
David Rubenstein
Baltimore, MD 21287 map
Phone: 410-614-3917
Fax: 410-614-1491

Expertise

Meningitis, Pediatric Infectious Disease, Pediatric Infectious Diseases, Septic Shock

Research Interests

central nervous sytem infection; sepsis

Biography

Dr. Kwang Sik Kim is a professor of pediatrics at the Johns Hopkins University School of Medicine. Dr. Kim serves as the director of the Eudowood Division of Pediatric Infectious Diseases at the Johns Hopkins Children’s Center. He holds a joint appointment in molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health.

As a researcher, his chief interest is in the pathogenesis of sepsis and central nervous system (CNS) infections, using microbial genomics and proteomics. Sepsis and CNS infections are prevalent and remain the major causes of mortality and morbidity throughout the world; attempts to control such diseases have been hampered by incomplete knowledge of the pathogenesis. Dr. Kim’s group is the first to show, using E. coli, how bacteria translocate from blood to the CNS. His group is also one of the first to show that endotoxin requires soluble CD14 for activating endothelial cells. His continued investigations of microbes-host interactions pertaining to pathogenesis will lead to development of novel strategies (e.g., vaccines) to prevent sepsis and CNS infections.

Dr. Kim received his medical degree in 1971 from the Seoul National University in Korea. After serving three years in the Korean Air Force, he trained in pediatrics at Ellis Hospital in New York and Louisiana State University Division, Charity Hospital of Louisiana. A former fellow in pediatric infectious diseases at Harbor-UCLA Medical Center, UCLA School of Medicine, he left his post there as director of infectious diseases to join Johns Hopkins in 2000 as director of pediatric infectious diseases. At Johns Hopkins, he holds a joint appointment in molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health.

He has authored 250 peer-reviewed publications and has received several major awards, including the NIH's Fogarty Senior International Fellowship. He is a member of the American Association for the Advancement of Science, the Infectious Diseases Society of America, and the American Pediatric Society, among others.

...read more

    Additional Information

  • Education +

    Degrees

    • Seoul National University College of Medicine / MD (1971)

    Residencies

    • Medical Center of Louisiana at New Orleans-LSU Div / Pediatrics (1978)

    Fellowships

    • Los Angeles County-Harbor-UCLA Medical Center / Pediatric Infectious Diseases (1980)

    Certifications

    • American Board of Pediatrics / Pediatric Infectious Diseases (1994, 2008)
    • American Board of Pediatrics / Pediatrics (1979)
  • Research & Publications +

    Research Summary

    Dr. Kim’s chief research interest is in the pathogenesis of sepsis and central nervous system (CNS) infections, using microbial genomics and proteomics. Sepsis and CNS infections are prevalent and remain the major causes of mortality and morbidity throughout the world; attempts to control such diseases have been hampered by incomplete knowledge of the pathogenesis. Dr. Kim’s group is the first to show, using E. coli, how bacteria translocate from blood to the CNS. His group is also one of the first to show that endotoxin requires soluble CD14 for activating endothelial cells. His continued investigations of microbes-host interactions pertaining to pathogenesis will lead to development of novel strategies (e.g., vaccines) to prevent sepsis and CNS infections.

    Clinical Trial Keywords: antimicrobial agents, vaccines

    Selected Publications View all on PubMed

    Agostoni C, Kim KS. "Nutrition and the microbiome 2015." Pediatr Res. 2015 Jan;77(1-2):113-4. doi: 10.1038/pr.2014.195.

    Kumar G, Date OS, Kim KS, Manjunath R. "Infection of human amniotic and endothelial cells by Japanese encephalitis virus: Increased expression of HLA-F." Virology. 2014 Dec;471-473:29-37. doi: 10.1016/j.virol.2014.09.022. Epub 2014 Oct 20.

    Tan YC, Gill AK, Kim KS. "Treatment strategies for central nervous system infections: an update." Expert Opin Pharmacother. 2015 Feb;16(2):187-203. doi: 10.1517/14656566.2015.973851. Epub 2014 Oct 18.

    Kim MJ, Yang KW, Kim SS, Park SM, Park KJ, Kim KS, Choi YH, Cho KK, Hyun CG. "Chemical composition and anti-inflammation activity of essential oils from Citrus unshiu flower." Nat Prod Commun. 2014 May;9(5):727-30.

    Tarazi C, Agostoni C, Kim KS. "The placental microbiome and pediatric research." Pediatr Res. 2014 Sep;76(3):218-9. doi: 10.1038/pr.2014.95. Epub 2014 Jul 8. No abstract available.

  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    • Fogarty Senior International Fellowship, National Institutes of Health

    Memberships

    • American Association for the Advancement of Science
    • Infectious Diseases Society of America
    • American Pediatric Society
  • Videos & Media +
Is This You? Edit Profile
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.